PLA2G4A and pulmonary fibrosis: Nagase et al. demonstrated that cPLA(2)-downregulated mice with a disrupted PLA2G4A gene presented attenuated lung inflammation and fibrosis induced by bleomycin administration, suggesting that cPLA(2) is a key enzyme in the generation of proinflammatory eicosanoids in pulmonary fibrosis [44].